Diabeloop safely automates and personalizes the treatment of Type 1 diabetes
The DBLG1 is a self-learning algorithm that automates and personalizes the treatment of Type 1 diabetes. The therapeutic artificial intelligence contributes to reduce the heavy mental burden associated with this chronic condition.
Automated insulin delivery thanks to therapeutic artificial intelligence
The DBLG1 algorithm developed by Diabeloop is hosted on a dedicated handset and acts as a user interface. It is connected to a continuous glucose monitoring (CGM) and an insulin pump.
How does it work? Every 5 minutes, a glucose measurement is transmitted via Bluetooth technology to the handset. The DBLG1 artificial intelligence analyzes the data in real time, while considering the patient’s physiology, history and data entries (meals or exercise) to determine the correct dose of insulin to administer. That is what we call a hybrid closed-loop system.
Diabeloop DBLG1 is a medical device for the treatment of Type 1 diabetes in adults. This device is intended for single patient use and requires a prescription. For full indications for use and safety information see user manual. All content and information provided by this website is intended as informative and can not serve as a substitute for a health professional’s advice, diagnosis or prescription. All decisions related to your therapy and treatment should be discussed with your doctor.
DBLG1 has received CE marking.